Blood Test Predicts Alzheimer’s Progression in Cognitively Healthy Older Adults
Research shows the pTau217 biomarker can identify risk for cognitive decline and amyloid buildup before changes appear on brain scans.
Latest Articles
Editor's Top Picks
FDA Grants Breakthrough Status to Blood Test to Distinguish Schizophrenia and Bipolar Disorder
The mRNA-based test aims to provide objective data to help clinicians distinguish between psychiatric conditions that often share symptoms.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
CareDx to Acquire Oncology Diagnostics Company Naveris for $160 Million
CareDx will acquire Naveris for $160 million, adding a Medicare-reimbursed liquid biopsy platform for viral-mediated cancer monitoring to its precision medicine portfolio.
Equipment & Supply Spotlight
New Automated Blood Culture System Receives CE Mark for Infection Diagnosis
The BD BACTEC FXI Culture System has received CE marking under EU IVDR, offering automated blood culture diagnostics with a reported 15% faster pathogen detection than previous models, according to clinical study data.
News, Know-How & Standards
Disease Detection & Understanding
Creatv Bio’s Liquid Biopsy Test Supports CytoDyn Phase 2 Colorectal Cancer Study
LifeTracDx blood test will evaluate PD-L1 expression changes as exploratory biomarker in trial combining leronlimab with standard therapies.
